Your browser doesn't support javascript.
loading
Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies.
Vicario, Rocio; Peg, Vicente; Morancho, Beatriz; Zacarias-Fluck, Mariano; Zhang, Junjie; Martínez-Barriocanal, Águeda; Navarro Jiménez, Alexandra; Aura, Claudia; Burgues, Octavio; Lluch, Ana; Cortés, Javier; Nuciforo, Paolo; Rubio, Isabel T; Marangoni, Elisabetta; Deeds, James; Boehm, Markus; Schlegel, Robert; Tabernero, Josep; Mosher, Rebecca; Arribas, Joaquín.
Afiliação
  • Vicario R; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, 08193, Bellaterra, Spain.
  • Peg V; Pathology Department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Morancho B; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Zacarias-Fluck M; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Zhang J; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Martínez-Barriocanal Á; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Navarro Jiménez A; Pathology Department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Aura C; Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Burgues O; Pathology Department, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain.
  • Lluch A; Oncology Department, Hospital Clínico Universitario, INCLIVA Biomedical Research Institute, 46010, Valencia, Spain.
  • Cortés J; Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Nuciforo P; Molecular Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Rubio IT; Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Marangoni E; Translational Research Department, Institut Curie, 75005, Paris, France.
  • Deeds J; Novartis Oncology Translational Research, Cambridge, MA, 02139, United States of America.
  • Boehm M; Novartis Pharma AG, Postfach, CH-4002, Basel, Switzerland.
  • Schlegel R; Novartis Oncology Translational Research, Cambridge, MA, 02139, United States of America.
  • Tabernero J; Clinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain.
  • Mosher R; Novartis Oncology Translational Research, Cambridge, MA, 02139, United States of America.
  • Arribas J; Preclinical Oncology Program, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, 08035, Barcelona, Spain; Department of Biochemistry and Molecular Biology, Universitat Autònoma de Barcelona, Campus de la UAB, 08193, Bellaterra, Spain; Institució Catalana de Recerca i Estu
PLoS One ; 10(6): e0129876, 2015.
Article em En | MEDLINE | ID: mdl-26075403

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Amplificação de Genes / Receptor ErbB-2 / Terapia de Alvo Molecular / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Amplificação de Genes / Receptor ErbB-2 / Terapia de Alvo Molecular / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article